<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>76(4)</volume><submitter>Abo-Zeid Salim MA</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The shivering effect after spinal anesthesia in total knee arthroplasty (TKA) is challenging for anesthesiologists. This study aimed to compare two administration routes of dexmedetomidine as a post-neuraxial shivering prevention measure and an adjunctive analgesic and sedative agent.&lt;h4>Methods&lt;/h4>Fifty-six patients were randomly allocated into two equal groups. The intravenous dexmedetomidine (IV dex) group received an IV infusion of 0.5 µg/kg dexmedetomidine diluted in 20 ml saline and an adductor canal block (ACB) consisting of 20 ml of 0.25% levobupivacaine and 1 ml saline. The adductor canal block dexmedetomidine (ACB dex) group received a 20 ml IV infusion of saline and an ACB consisting of 20 ml 0.25% levobupivacaine and 1 ml of 0.5 µg/kg dexmedetomidine.&lt;h4>Results&lt;/h4>The incidence of shivering 1 h post spinal anesthesia was equal in both groups (50%); however, the shivering grade was significantly lower in the IV dex group 1 h postoperatively. The onset of sensory block was significantly later in the IV dex group (22.14 ± 2.52 min) than in the ACB dex group (12 ± 3.31 min). Postoperative analgesic duration (h) was significantly longer in the ACB dex group (12.28 ± 4.47) compared to the IV dex group (9.28 ± 1.90). The sedation scores were also significantly higher in the IV dex group in the preoperative, intraoperative, and immediate postoperative periods.&lt;h4>Conclusions&lt;/h4>While perineural ACB dexmedetomidine had similar intraoperative anti-shivering with less sedative effects as IV dexmedetomidine, it was associated with both less shivering control and superior analgesia post-TKA under spinal anesthesia.</pubmed_abstract><journal>Korean journal of anesthesiology</journal><pagination>307-316</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10391069</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Intravenous versus perineural dexmedetomidine as adjuvant in adductor canal block for total knee arthroplasty.</pubmed_title><pmcid>PMC10391069</pmcid><pubmed_authors>Abo-Zeid Salim MA</pubmed_authors><pubmed_authors>Elbadrawy RE</pubmed_authors><pubmed_authors>Bakrey S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intravenous versus perineural dexmedetomidine as adjuvant in adductor canal block for total knee arthroplasty.</name><description>&lt;h4>Background&lt;/h4>The shivering effect after spinal anesthesia in total knee arthroplasty (TKA) is challenging for anesthesiologists. This study aimed to compare two administration routes of dexmedetomidine as a post-neuraxial shivering prevention measure and an adjunctive analgesic and sedative agent.&lt;h4>Methods&lt;/h4>Fifty-six patients were randomly allocated into two equal groups. The intravenous dexmedetomidine (IV dex) group received an IV infusion of 0.5 µg/kg dexmedetomidine diluted in 20 ml saline and an adductor canal block (ACB) consisting of 20 ml of 0.25% levobupivacaine and 1 ml saline. The adductor canal block dexmedetomidine (ACB dex) group received a 20 ml IV infusion of saline and an ACB consisting of 20 ml 0.25% levobupivacaine and 1 ml of 0.5 µg/kg dexmedetomidine.&lt;h4>Results&lt;/h4>The incidence of shivering 1 h post spinal anesthesia was equal in both groups (50%); however, the shivering grade was significantly lower in the IV dex group 1 h postoperatively. The onset of sensory block was significantly later in the IV dex group (22.14 ± 2.52 min) than in the ACB dex group (12 ± 3.31 min). Postoperative analgesic duration (h) was significantly longer in the ACB dex group (12.28 ± 4.47) compared to the IV dex group (9.28 ± 1.90). The sedation scores were also significantly higher in the IV dex group in the preoperative, intraoperative, and immediate postoperative periods.&lt;h4>Conclusions&lt;/h4>While perineural ACB dexmedetomidine had similar intraoperative anti-shivering with less sedative effects as IV dexmedetomidine, it was associated with both less shivering control and superior analgesia post-TKA under spinal anesthesia.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-04-18T22:34:13.447Z</modification><creation>2025-04-07T10:20:19.474Z</creation></dates><accession>S-EPMC10391069</accession><cross_references><pubmed>36732321</pubmed><doi>10.4097/kja.22579</doi></cross_references></HashMap>